Baxter International (BAX) Receivables - Other (2009 - 2026)

Baxter International (BAX) has 18 years of Receivables - Other data on file, last reported at $136.0 million in Q1 2026.

• Receivables - Other for Q1 2026 came in at $136.0 million, up 3.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $136.0 million (up 3.03% YoY), and the FY2025 annual result was $147.0 million, up 10.53% from the prior year.
• Receivables - Other declined to $136.0 million in Q1 2026 per BAX's latest filing, from $147.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $229.0 million in Q3 2022 and troughed at $71.0 million in Q4 2022.
• A 5-year average of $158.4 million and a median of $153.0 million in 2024 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other jumped 3171.43% in 2022, then retreated 29.26% in 2023.
• A 5-year view of Receivables - Other shows it stood at $71.0 million in 2022, then soared by 132.39% to $165.0 million in 2023, then dropped by 19.39% to $133.0 million in 2024, then gained by 10.53% to $147.0 million in 2025, then decreased by 7.48% to $136.0 million in 2026.
• Business Quant data shows BAX's Receivables - Other at $136.0 million in Q1 2026, $147.0 million in Q4 2025, and $138.0 million in Q3 2025.